Evidence map›Paper›PMID 32664890›Full record

Observational studyBMC nephrology2020

Renal arteriography with endovascular ultrasound for the management of renal infarction patients.

Fabrice Ivanes, Jean Dewaele, Caroline Touboul, Philippe Gatault, Bénédicte Sautenet, Christelle Barbet, Matthias Büchler, Laurent Quilliet, Denis Angoulvant, Jean-Michel Halimi

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Fabrice IvanesDepartment of Cardiology, CHRU Tours, Tours, France. fabrice.ivanes@univ-tours.fr.ORCID 0000-0003-2407-6387
Jean DewaeleDepartment of Cardiology, CHRU Tours, Tours, France.
Caroline TouboulDepartment of Cardiology, CHRU Tours, Tours, France.
Philippe GataultEA 4245 T2I & Loire Valley Cardiovascular Collaboration, Université de Tours, Tours, France.
Bénédicte SautenetDepartment of Nephrology, CHRU de Tours, Tours, France.
Christelle BarbetDepartment of Nephrology, CHRU de Tours, Tours, France.
Matthias BüchlerEA 4245 T2I & Loire Valley Cardiovascular Collaboration, Université de Tours, Tours, France.
Laurent QuillietDepartment of Cardiology, CHRU Tours, Tours, France.
Denis AngoulvantDepartment of Cardiology, CHRU Tours, Tours, France.
Jean-Michel HalimiEA 4245 T2I & Loire Valley Cardiovascular Collaboration, Université de Tours, Tours, France.
Centre Hospitalier Universitaire de Tours · FRUniversité de Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal infarction (RI) is a rare disease with poor prognosis. Appropriate secondary prevention treatment is essential and requires an exhaustive etiological assessment. We aimed to determine whether invasive endovascular explorations may improve the diagnostic process and change the secondary prevention treatment strategy in RI patients.

methodsWe report a retrospective observational study of 25 RI patients referred to Tours University Hospital between 2011 and 2018 for etiological investigation including renal arteriography and intravascular ultrasonography (IVUS). We sought for antithrombotic treatment regimen, vital status, bleeding and ischemic outcomes during the median follow-up of 59 months.

resultsInvasive explorations showed local arterial disease in 14 patients (56%). This led to a diagnosis or change in diagnosis in 9 patients (36%) and to a change in antithrombotic strategy in 56% of cases, with an increased prescription of antiplatelet therapy. No patient died, only two patients (8%) had persistent mild renal insufficiency. One IVUS complication was reported and treated without any significant long-term consequences.

conclusionInvasive endovascular investigations of RI may modify the secondary prevention treatment through a better assessment of the aetiology of RI. Multicentric randomized studies are necessary to advocate the hypothesis that invasive exploration of renal artery can improve long-term prognosis.

Indexed as

AdultAngiographyAnticoagulantsAtherosclerosisAtrial FibrillationEmbolismFemaleHumansInfarctionKidney DiseasesMaleMiddle AgedPlatelet Aggregation InhibitorsRenal ArteryRenal Artery ObstructionSecondary PreventionAnticoagulantsPlatelet Aggregation InhibitorsIntravascular ultrasoundRenal arteriographyRenal infarctionSecondary prevention

Identifiers

PMID32664890
PMCPMC7362568
OpenAlexW3042309144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.